PMA device
MynxGrip and Mynx Ace Vascular Closure Device
Cordis US Corporation · Device, Hemostasis, Vascular (MGB, Class III) · First FDA decision Jul 30, 2014, newest Nov 16, 2018Vascular access
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
4
Naming "MynxGrip"
MAUDE reports
4,230
Brand "MynxGrip", since 2015
PubMed studies
16
Mentioning "MynxGrip"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing MynxGrip and Mynx Ace Vascular Closure Device
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- MynxGrip and Mynx Ace Vascular Closure DevicePMA supplement
P040044-S078 · Decided Nov 16, 2018 · 361 days after receipt · Normal 180 Day Track
Device type: Device, hemostasis, vascular (MGB) · Cardiology
- MynxGrip Vascular Closure DevicePMA supplement
P040044-S081 · Decided Jul 10, 2018 · 55 days after receipt · Normal 180 Day Track No User Fee
Device type: Device, hemostasis, vascular (MGB) · Cardiology
- MYNXGRIP VASCULAR CLOSURE DEVICE (5F, 6F/7F)PMA supplement
P040044-S068 · Decided Sep 6, 2016 · 274 days after receipt · Normal 180 Day Track No User Fee
Device type: Device, hemostasis, vascular (MGB) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "MynxGrip", any status and sponsor, newest update first.
- Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure DevicePivotal-lookingCompleted
Cordis US Corp.Not on our public-company list
NCT03923387 · 306 participants · Start Apr 24, 2019 · Primary completion Oct 22, 2020
Device: MynxGrip · For: Endovascular
Sites: Beijing, China
- Safety and Effectiveness of the Vascular Closure Device for Femoral Artery Hemostasis in Patients of Femoral Artery PuncturePivotal-lookingNot yet recruiting
Shanghai Bomaian Medical Technology Co., LtdNot on our public-company list
NCT07279220 · 238 participants (planned) · Start Dec 29, 2025 · Primary completion Mar 2, 2026
Device: Vascular Closure Device Manufactured by Shanghai Bomaian Medical Technology Co., Ltd.; MynxGrip Vascular Closure Device Manufactured by Cordis US Corp · For: Femoral Artery Puncture; Vascular Closure Device; Hemostasis
Sites: Chongqing, China
- The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site ClosurePivotal-lookingCompleted
Medstar Health Research InstituteAcademic, hospital or other
NCT02438475 · 208 participants · Start Jun 2015 · Primary completion Aug 2017
Device: Mynx Vascular Closure System · For: Cardiac Diagnostic Procedure; Cardiac Interventional Procedure; Femoral Access Site Closure
Sites: Washington D.C., District of Columbia; Clinton, Maryland
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "MynxGrip", and for the whole product code for context.
This brand
4,230 reports: 3,650 malfunction, 564 injury, 14 death
Whole product code MGB
93,533 reports: 17,154 malfunction, 76,023 injury, 315 death
Newest reports for this brand
- MYNXGRIPMalfunction
3004939290-2026-01550 · Received Oct 30, 2026 · Event dated Sep 30, 2026
Device type: Device, Hemostasis, Vascular (MGB)
Device problem as coded: Failure to Fire
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- MYNXGRIPMalfunction
3004939290-2026-01508 · Received Oct 22, 2026 · Event dated Sep 24, 2026
Device type: Device, Hemostasis, Vascular (MGB)
Device problem as coded: Failure to Advance; Difficult to Advance
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- MYNXGRIPMalfunction
3004939290-2026-01497 · Received Oct 21, 2026 · Event dated Jul 8, 2026
Device type: Device, Hemostasis, Vascular (MGB)
Device problem as coded: Activation, Positioning or Separation Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- MYNXGRIP 5F, REF MX5021, Vascular Closure Device (VCD). Used to seal femoral arterial and femoral venous access sites.Open, Classified
Z-0674-2024 · Started Nov 28, 2023 · Posted by FDA Jan 5, 2024
Reason given: Cordis became aware that the label for the carton box containing 10 units is incorrect for some boxes of two lots of MynxGrip. The carton box from lot F2322902 (Item MX5021, MynxGrip 5F) as labeled as lot F2322903 (MX6721, MynxGrip 6/7F) and product from lot F2322903 (MX6721, MynxGrip 6/7F) was labeled as F2322902...
Cause as FDA categorized it: Labeling Change Control · Device type: Device, Hemostasis, Vascular (MGB)
- MYNXGRIP 6F/7F, REF MX6721, Vascular Closure Device (VCD). Used to seal femoral arterial and femoral venous access sitesOpen, Classified
Z-0675-2024 · Started Nov 28, 2023 · Posted by FDA Jan 5, 2024
Reason given: Cordis became aware that the label for the carton box containing 10 units is incorrect for some boxes of two lots of MynxGrip. The carton box from lot F2322902 (Item MX5021, MynxGrip 5F) as labeled as lot F2322903 (MX6721, MynxGrip 6/7F) and product from lot F2322903 (MX6721, MynxGrip 6/7F) was labeled as F2322902...
Cause as FDA categorized it: Labeling Change Control · Device type: Device, Hemostasis, Vascular (MGB)
AccessClosure, Inc., A Cardinal Health Company
Z-2329-2016 · Started Jul 13, 2016 · Posted by FDA Aug 3, 2016
Reason given: A total of 70 6F/7F Mynx Grip devices were shipped from a distributor using improper transport/packaging configurations.
Cause as FDA categorized it: Process control · Device type: Device, Hemostasis, Vascular (MGB)
Published research
The most relevant PubMed records for "MynxGrip"[tiab]. The summary above synthesizes these.
- Feasibility of Mynxgrip®-Assisted Percutaneous Transhepatic Portal Venous Access Closure.
Tan GXV, Yong EXZ, Sathyanarayana R, et al. · Cardiovasc Intervent Radiol · 2020
- Comparison of MynxGrip vascular closure device and manual compression for closure after femoral access angiography: a randomized controlled trial: the closure devices used in every day practice study, CLOSE-UP III trial.
Jakobsen L, Holm NR, Maeng M, et al. · BMC Cardiovasc Disord · 2022Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- MynxGrip vascular closure device use in pediatric neurointerventional procedures.
Shokuhfar T, Hurley MC, Al-Smadi A, et al. · J Neurosurg Pediatr · 2018Evaluation Study
- Endovascular foreign body removal of a MynxGrip polyethylene glycol (PEG) sealant embolus using a cerebral stent retriever.
Shamseldin M, Bergert H, Neumeister A, et al. · CVIR Endovasc · 2021
- MynxGrip for Closure of Antegrade Puncture After Peripheral Interventions With Same-Day Discharge.
Pruski MJ, Blachut AM, Konkolewska M, et al. · Vasc Endovascular Surg · 2017
- MynxGrip® vascular closure device versus manual compression for hemostasis of percutaneous transfemoral venous access closure: Results from a prospective multicenter randomized study.
Ben-Dor I, Craig P, Torguson R, et al. · Cardiovasc Revasc Med · 2018Multicenter Study, Randomized Controlled Trial
- Use of the MynxGrip vascular closure device in patients undergoing interventional diagnosis or treatment: The PANDA multicenter, open-label, randomized controlled trial.
Song L, Zhao J, Xiong F, et al. · J Vasc Access · 2024Multicenter Study, Randomized Controlled Trial
- Hemostasis After Brachial Artery Access With the MynxGrip Device: A Case Report.
Giordano A, Messina S, Maresca G, et al. · Clin Med Insights Cardiol · 2018Case Reports
- Safety and feasibility of a novel vascular closure device in neurointerventional procedures.
Taha A, Walsh EK, Wright KA, et al. · Interv Neuroradiol · 2013
- Endoscopic repair of an injured internal carotid artery utilizing femoral endovascular closure devices.
Van Rompaey J, Bowers G, Radhakrishnan J, et al. · Laryngoscope · 2014Research Support, Non-U.S. Gov't
- Mynx Vascular Closure Device in Arterial Endovascular Procedures.
Scott MC, Spencer HJ, Ali AT, et al. · Ann Vasc Surg · 2018Comparative Study
- Successful Use of the MYNXGRIP Closure Device during Repeated Transbrachial Percutaneous Peripheral Intervention.
Hertting K, Raut W · Case Rep Vasc Med · 2015
Other devices of this type
Also filed under product code MGB.
- Angio-Seal Vascular Closure DeviceTerumo Medical Corporation · PMA 2013
- Perclose ProGlide® Suture-Mediated Closure SystemAbbott Vascular, Inc. · PMA 2025
- StarClose SE® Vascular Surgical SystemAbbott Vascular Devices · PMA 2025
- Mynx Vascular Closure DeviceCordis US Corporation · PMA 2013
- MANTA Vascular Closure DeviceTeleflex Medical, LLC · PMA 2024
- Vascade Vascular Closure System (VCS)Cardiva Medical, Inc. · PMA 2023
- Vascular Solutions Duett Sealing DeviceVascular Solutions, Inc. · PMA 2010
- Angio-Seal Hemostatic Puncture Closure DeviceTerumo Medical Corporation · PMA 2000
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.